Renovaro Inc logo

Renovaro Inc

NAS:RENB (USA)  
$ 2.01 +0.02 (+1%) 10:08 PM EST
At Loss
P/B:
3.10
Market Cap:
$ 288.77M
Enterprise V:
$ 295.92M
Volume:
199.58K
Avg Vol (2M):
208.04K
Also Trade In:
Volume:
199.58K
At Loss
Avg Vol (2M):
208.04K

Business Description

Description
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset 0.75
Debt-to-Equity 0.17
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.26
9-Day RSI 25.91
14-Day RSI 28.49
6-1 Month Momentum % 132.5
12-1 Month Momentum % 326.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.17
Quick Ratio 0.17
Cash Ratio 0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.1
Shareholder Yield % -0.37
Name Current Vs Industry Vs History
ROE % -76.39
ROA % -61.93
ROIC % -30.67
ROC (Joel Greenblatt) % -2818.16
ROCE % -73.19

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 3.1
EV-to-EBIT -7.35
EV-to-EBITDA -7.37
EV-to-FCF -25.75
Earnings Yield (Greenblatt) % -13.61
FCF Yield % -3.98

Financials (Next Earnings Date:2024-03-07 Est.)

RENB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RENB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Renovaro Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.7
Beta 0.52
Volatility % 391.7
14-Day RSI 28.49
14-Day ATR ($) 0.400896
20-Day SMA ($) 3.3
12-1 Month Momentum % 326.61
52-Week Range ($) 0.3928 - 5.25
Shares Outstanding (Mil) 143.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Renovaro Inc Filings

Filing Date Document Date Form
No Filing Data

Renovaro Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Renovaro Inc Frequently Asked Questions

What is Renovaro Inc(RENB)'s stock price today?
The current price of RENB is $2.01. The 52 week high of RENB is $5.25 and 52 week low is $0.39.
When is next earnings date of Renovaro Inc(RENB)?
The next earnings date of Renovaro Inc(RENB) is 2024-03-07 Est..
Does Renovaro Inc(RENB) pay dividends? If so, how much?
Renovaro Inc(RENB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1